Records 1 - 3
| Associations of genetically proxied inhibition of HMG-CoA reductase, NPC1L1, and PCSK9 with breast cancer and prostate cancer.
Breast cancer research : BCR 2022 Feb 24 (1): 12.
Sun Lulu, Ding Huan, Jia Yiming, Shi Mengyao, Guo Daoxia, Yang Pinni, Wang Yu, Liu Fanghua, Zhang Yonghong, Zhu Zhengb
| Body mass index and the association between low-density lipoprotein cholesterol as predicted by HMGCR genetic variants and breast cancer risk.
International journal of epidemiology 2019 Mar .
Kar Siddhartha P, Brenner Hermann, Giles Graham G, Huo Dezheng, Milne Roger L, Rennert Gad, Simard Jacques, Zheng Wei, Burgess Stephen, Pharoah Paul D
| Blood lipid genetic scores, the HMGCR gene and cancer risk: a Mendelian randomization study.
International journal of epidemiology 2017 Nov .
Orho-Melander Marju, Hindy George, Borgquist Signe, Schulz Christina-Alexandra, Manjer Jonas, Melander Olle, Stocks Tan